Article
- Author:
- Amy Karon
Publish date: December 3, 2016
SAN DIEGO – Novel microcapsules loaded with factor VIII outperformed systemic factor VIII infusions in models of hemophilia A with inhibitory...
Article
- Author:
- Amy Karon
Publish date: December 1, 2016
Yoga may be a feasible and safe add-on therapy for patients with irritable bowel syndrome, based on a systematic review of six randomized controlle...
Article
- Author:
- Amy Karon
Publish date: December 1, 2016
Patients with diarrhea-predominant irritable bowel syndrome who responded to rifaximin but relapsed after completing treatment were significantly m...
News
- Author:
- Amy Karon
Publish date: December 1, 2016
Mobile health indexes for remotely monitoring Crohn’s disease and ulcerative colitis accurately identified clinically active disease, and changed s...
Article
- Author:
- Amy Karon
Publish date: December 1, 2016
Liver cancer took nearly four times longer to progress after yttrium-90 radioembolization than after conventional transarterial chemoembolization, ...
Article
- Author:
- Amy Karon
Publish date: November 30, 2016
BOSTON - Amid a plethora of quality research, several abstracts stood out at the annual meeting of the American Association for the Study of Liver ...
Article
- Author:
- Amy Karon
Publish date: November 29, 2016
Among patients with hepatocellular carcinoma, rates of sustained viral response to direct-acting regimens for hepatitis C virus were 79% for genoty...
Article
- Author:
- Amy Karon
Publish date: November 28, 2016
BOSTON - Metabolomics of liquid biopsies noninvasively identified nonalcoholic fatty liver disease with and without steatosis, and assessed t...
Article
- Author:
- Amy Karon
Publish date: November 21, 2016
BOSTON – When given with ribavirin, a fixed-dose combination of sofosbuvir/velpatasvir (Epclusa) achieved a sustained viral response at 12 we...
Article
- Author:
- Amy Karon
Publish date: November 21, 2016
BOSTON – All phenotypes of nonalcoholic fatty liver disease can progress or regress even without pharmacologic intervention, according to a p...
Article
- Author:
- Amy Karon
Publish date: November 21, 2016
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards ...
Article
- Author:
- Amy Karon
Publish date: November 17, 2016
BOSTON
Article
- Author:
- Amy Karon
Publish date: November 14, 2016
BOSTON - Oral zinc supplementation was associated with maintenance of liver function and suppression of hepatocellular carcinoma in a retrospective...
Article
- Author:
- Amy Karon
Publish date: November 13, 2016
BOSTON
Article
- Author:
- Amy Karon
Publish date: November 11, 2016
BOSTON - The investigational peroxisome proliferator-activated receptor delta agonist MBX-8025 exhibited a "striking anticholestatic effect&qu...
